<Suppliers Price>

Cloricromenehydrochloride

Names

[ CAS No. ]:
74697-28-2

[ Name ]:
Cloricromenehydrochloride

[Synonym ]:
AD6
Cloricromen hydrochloride
Proendotel (TN)
8-Chloro-3-(2-diethylaminoethyl)-7-ethoxycarbonylmethoxy-4-methylcoumarin hydrochloride
Cloricromen hydrohloride

Biological Activity

[Description]:

Cloricromen (Cloricromene) hydrochloride is a platelet aggregation inhibitor. Cloricromen hydrochloride can inhibit platelet aggregation in man and in experimental thrombosis[1].

[Related Catalog]:

Research Areas >> Cardiovascular Disease
Signaling Pathways >> Others >> Others

[References]

[1]. G Orefice, et al. No effect of cloricromen on some coagulation parameters in patients with ischaemic cerebrovascular disease. J Int Med Res. 1994 Sep-Oct;22(5):287-91.  

Chemical & Physical Properties

[ Boiling Point ]:
538ºC at 760 mmHg

[ Melting Point ]:
221-222.3ºC

[ Molecular Formula ]:
C20H27Cl2NO5

[ Molecular Weight ]:
432.33800

[ Flash Point ]:
279.2ºC

[ Exact Mass ]:
431.12700

[ PSA ]:
68.98000

[ LogP ]:
4.38300

MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xn: Harmful;

[ Risk Phrases ]:
22

[ RIDADR ]:
NONH for all modes of transport

[ RTECS ]:
AF8970000

Articles

Cloricromene in endotoxemia: role of NF-kappaB.

Naunyn Schmiedebergs Arch. Pharmacol. 370(2) , 140-5, (2004)

In this study we investigated, for the first time in vivo, the effect of cloricromene, a cumarine derivative, on NF-kappaB activation in endotoxin-treated rats. Endotoxemia was induced in male rats by...

Tumor necrosis factor induces E-selectin production in splanchnic artery occlusion shock.

Am. J. Physiol. 268(4 Pt 2) , H1412-7, (1995)

Splanchnic arteries were clamped for 45 min to induce splanchnic artery occlusion (SAO) shock in anesthetized rats. Sham-operated animals were used as controls. Survival time, serum tumor necrosis fac...

Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene.

AAPS PharmSciTech 7(1) , E27, (2006)

The purpose of this study was to improve the stability of cloricromene (AD6) in ophthalmic formulations and its drug availability at the ocular level. To this end, AD6-loaded polymeric nanoparticle su...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.